Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024 ...Middle East

PR Newswire - News
Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024
- New proteomic analyses show that rezpegaldesleukin increases the protein levels of immune-regulating pathways while reducing specific serum proteins known to be elevated in patients with atopic dermatitis - SAN FRANCISCO, Sept. 25, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR)...

Hence then, the article about nektar therapeutics announces multiple presentations for rezpegaldesleukin at eadv 2024 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024 )

Apple Storegoogle play

Last updated :

Also on site :